Research Article
The Effect of Artificial Liver Support System on Prognosis of HBV-Derived Hepatorenal Syndrome: A Retrospective Cohort Study
Table 5
Summary of the results of multivariate analyses of 28-day mortality in HBV-derived HRS patients after PSM who received ALSS versus SMT treatment with risk stratification by number of organ failures or AKI degree.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Model 1 was adjusted for age and sex. Model 2 was adjusted for age, sex, neutrophils, alanine aminotransferase (ALT), albumin, serum bilirubin, COSSH-ACLFs, and international normalized ratio (INR). AKI: acute kidney injury; SMT: standard medical treatment; ALSS: artificial liver support system. |